US Stock MarketDetailed Quotes

TPST Tempest Therapeutics

Watchlist

1.330
-0.070-5.00%

Close Oct 1 16:00 ET

1.340
+0.010+0.75%

Pre 05:44 ET

33.53MMarket Cap-831P/E (TTM)

Tempest Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

28.27%9.58M

5.18%7.97M

-15.83%29.16M

-15.89%7.51M

-24.84%6.59M

-14.86%7.47M

-7.11%7.58M

28.36%34.64M

21.75%8.93M

13.38%8.77M

Selling and administrative expenses

22.63%3.75M

25.18%3.63M

-3.75%11.66M

6.08%3.33M

-15.26%2.37M

-2.21%3.05M

-4.88%2.9M

23.35%12.11M

19.71%3.14M

-9.92%2.8M

-General and administrative expense

22.63%3.75M

25.18%3.63M

-3.75%11.66M

6.08%3.33M

-15.26%2.37M

-2.21%3.05M

-4.88%2.9M

23.35%12.11M

19.71%3.14M

-9.92%2.8M

Research and development costs

32.18%5.84M

-7.23%4.34M

-22.32%17.5M

-27.80%4.18M

-29.33%4.22M

-21.85%4.42M

-8.44%4.68M

31.23%22.53M

22.88%5.79M

29.01%5.97M

Operating profit

-28.27%-9.58M

-5.18%-7.97M

15.83%-29.16M

15.89%-7.51M

24.84%-6.59M

14.86%-7.47M

7.11%-7.58M

-28.36%-34.64M

-21.75%-8.93M

-13.38%-8.77M

Net non-operating interest income expense

110.81%12K

227.27%70K

65.72%-349K

330.36%723K

4.11%-373K

71.83%-111K

83.33%-55K

20.16%-1.02M

142.00%168K

-4.01%-389K

Non-operating interest income

57.38%384K

51.56%438K

83.33%1.1M

----

248.57%244K

9,533.33%289K

8,471.43%600K

----

Non-operating interest expense

4.79%372K

6.98%368K

-10.44%1.45M

-12.73%377K

-4.11%373K

-23.49%355K

3.30%344K

26.21%1.62M

27.81%432K

-10.98%389K

Other net income (expense)

129.41%15K

-106.82%-697K

-15.96%179K

-24.39%-51K

-337K

213K

Other non- operating income (expenses)

----

129.41%15K

-106.82%-697K

-15.96%179K

----

-24.39%-51K

---337K

--213K

Income before tax

-26.24%-9.57M

-3.51%-7.9M

17.41%-29.49M

17.74%-7.49M

24.15%-6.79M

17.31%-7.58M

10.07%-7.64M

-26.17%-35.71M

-17.02%-9.1M

-10.32%-8.95M

Income tax

Net income

-26.24%-9.57M

-3.51%-7.9M

17.41%-29.49M

17.74%-7.49M

24.15%-6.79M

17.31%-7.58M

10.07%-7.64M

-26.17%-35.71M

-17.02%-9.1M

-10.32%-8.95M

Net income continuous Operations

-26.24%-9.57M

-3.51%-7.9M

17.41%-29.49M

17.74%-7.49M

24.15%-6.79M

17.31%-7.58M

10.07%-7.64M

-26.17%-35.71M

-17.02%-9.1M

-10.32%-8.95M

Minority interest income

Net income attributable to the parent company

-26.24%-9.57M

-3.51%-7.9M

17.41%-29.49M

17.74%-7.49M

24.15%-6.79M

17.31%-7.58M

10.07%-7.64M

-26.17%-35.71M

-17.02%-9.1M

-10.32%-8.95M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-26.24%-9.57M

-3.51%-7.9M

17.41%-29.49M

17.74%-7.49M

24.15%-6.79M

17.31%-7.58M

10.07%-7.64M

-26.17%-35.71M

-17.02%-9.1M

-10.32%-8.95M

Basic earnings per share

22.22%-0.42

34.55%-0.36

38.19%-1.91

46.03%-0.34

27.27%-0.48

31.65%-0.54

53.39%-0.55

58.63%-3.09

44.04%-0.63

45.45%-0.66

Diluted earnings per share

22.22%-0.42

34.55%-0.36

38.19%-1.91

46.03%-0.34

27.27%-0.48

31.65%-0.54

53.39%-0.55

58.63%-3.09

44.04%-0.63

45.45%-0.66

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	28.27%9.58M	5.18%7.97M	-15.83%29.16M	-15.89%7.51M	-24.84%6.59M	-14.86%7.47M	-7.11%7.58M	28.36%34.64M	21.75%8.93M	13.38%8.77M
Selling and administrative expenses	22.63%3.75M	25.18%3.63M	-3.75%11.66M	6.08%3.33M	-15.26%2.37M	-2.21%3.05M	-4.88%2.9M	23.35%12.11M	19.71%3.14M	-9.92%2.8M
-General and administrative expense	22.63%3.75M	25.18%3.63M	-3.75%11.66M	6.08%3.33M	-15.26%2.37M	-2.21%3.05M	-4.88%2.9M	23.35%12.11M	19.71%3.14M	-9.92%2.8M
Research and development costs	32.18%5.84M	-7.23%4.34M	-22.32%17.5M	-27.80%4.18M	-29.33%4.22M	-21.85%4.42M	-8.44%4.68M	31.23%22.53M	22.88%5.79M	29.01%5.97M
Operating profit	-28.27%-9.58M	-5.18%-7.97M	15.83%-29.16M	15.89%-7.51M	24.84%-6.59M	14.86%-7.47M	7.11%-7.58M	-28.36%-34.64M	-21.75%-8.93M	-13.38%-8.77M
Net non-operating interest income expense	110.81%12K	227.27%70K	65.72%-349K	330.36%723K	4.11%-373K	71.83%-111K	83.33%-55K	20.16%-1.02M	142.00%168K	-4.01%-389K
Non-operating interest income	57.38%384K	51.56%438K	83.33%1.1M	----	----	248.57%244K	9,533.33%289K	8,471.43%600K	----	----
Non-operating interest expense	4.79%372K	6.98%368K	-10.44%1.45M	-12.73%377K	-4.11%373K	-23.49%355K	3.30%344K	26.21%1.62M	27.81%432K	-10.98%389K
Other net income (expense)			129.41%15K	-106.82%-697K	-15.96%179K			-24.39%-51K	-337K	213K
Other non- operating income (expenses)	----	----	129.41%15K	-106.82%-697K	-15.96%179K	----	----	-24.39%-51K	---337K	--213K
Income before tax	-26.24%-9.57M	-3.51%-7.9M	17.41%-29.49M	17.74%-7.49M	24.15%-6.79M	17.31%-7.58M	10.07%-7.64M	-26.17%-35.71M	-17.02%-9.1M	-10.32%-8.95M
Income tax	0	0	0	0	0	0	0	0	0	0
Net income	-26.24%-9.57M	-3.51%-7.9M	17.41%-29.49M	17.74%-7.49M	24.15%-6.79M	17.31%-7.58M	10.07%-7.64M	-26.17%-35.71M	-17.02%-9.1M	-10.32%-8.95M
Net income continuous Operations	-26.24%-9.57M	-3.51%-7.9M	17.41%-29.49M	17.74%-7.49M	24.15%-6.79M	17.31%-7.58M	10.07%-7.64M	-26.17%-35.71M	-17.02%-9.1M	-10.32%-8.95M
Minority interest income
Net income attributable to the parent company	-26.24%-9.57M	-3.51%-7.9M	17.41%-29.49M	17.74%-7.49M	24.15%-6.79M	17.31%-7.58M	10.07%-7.64M	-26.17%-35.71M	-17.02%-9.1M	-10.32%-8.95M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-26.24%-9.57M	-3.51%-7.9M	17.41%-29.49M	17.74%-7.49M	24.15%-6.79M	17.31%-7.58M	10.07%-7.64M	-26.17%-35.71M	-17.02%-9.1M	-10.32%-8.95M
Basic earnings per share	22.22%-0.42	34.55%-0.36	38.19%-1.91	46.03%-0.34	27.27%-0.48	31.65%-0.54	53.39%-0.55	58.63%-3.09	44.04%-0.63	45.45%-0.66
Diluted earnings per share	22.22%-0.42	34.55%-0.36	38.19%-1.91	46.03%-0.34	27.27%-0.48	31.65%-0.54	53.39%-0.55	58.63%-3.09	44.04%-0.63	45.45%-0.66
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data